CIMETIDINE 10% / LIDOCAINE 5% / SALICYLIC ACID 40%
- Manufacturer
- Sincerus Florida, LLC
- Effective date
- 2019-04-24
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:28:29
Label at a glance#
ProductCIMETIDINE 10% / LIDOCAINE 5% / SALICYLIC ACID 40%
Active ingredientSALICYLIC ACID, LIDOCAINE, CIMETIDINE
Label structure4 sections
Label contents#
Full prescribing information#
Sincerus Florida, LLC adverse reactions.
Active, inactive
NDC 72934-2046-2 CIMETIDINE USP 10% / LIDOCAINE USP 5% / SALICYLIC ACID USP 40% Cream 30 gm
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| CIMETIDINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 8f48ba86-02a3-4def-9efa-3a8140fd7adf | Product name | 2 | 20250624 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72934-2046-2 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3aad-a910-e053-dadaa90a0b85 | CIMETIDINE 10% / LIDOCAINE 5% / SALICYLIC ACID 40% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72934-2046-2 | CIMETIDINE 10% / LIDOCAINE 5% / SALICYLIC ACID 40% | 30 g in 1 BOTTLE, PUMP | CREAM | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72934-2046 | CIMETIDINE 10% / LIDOCAINE 5% / SALICYLIC ACID 40% CREAM [SINCERUS FLORIDA, LLC] | 1 | Legacy NDC, 1 package rows | 20190501_874cd0d1-8711-225c-e053-2995a90af24b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72934-2046-2 | GM - Gram | 72934-2046 | fc8e6249-6a7e-484c-801d-7042e139a9ba | 1 | 2020-03-10 |
Products#
Every source-derived product name is available through these pages.
- CIMETIDINE 10% / LIDOCAINE 5% / SALICYLIC ACID 40%
- SALICYLIC ACID
- LIDOCAINE
- CIMETIDINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72934-2046 | 72934-2046-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| LIDOCAINE | 98PI200987 | ACTIB |
| CIMETIDINE | 80061L1WGD | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 874cd0d1-8712-225c-e053-2995a90af24b | 874cd0d1-8711-225c-e053-2995a90af24b | 2019-04-24 | Adverse reactions | 874cd0d1-8712-225c-e053-2995a90af24b 874cd0d1-8711-225c-e053-2995a90af24b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


